International Journal of Endocrinology / 2019 / Article / Tab 1

Research Article

Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism

Table 1

Patient general characteristics.

Gender ( )
Male, (%)133 (45.4)
Female, (%)160 (54.6)
Age (years,)
Median (range)59.9 (22-89)
Age at diagnosis (years,)
Median (range)56.5 (15-87)
Race ( )
Caucasian, (%)285 (97.3)
African, (%)1 (0.3)
Other or not specified, (%)7 (2.4)
Type of diagnosis ()
Histopathological, (%)254 (86.7)
Cytological, (%)17 (5.8)
Biochemical, (%)5 (1.7)
Other or not specified, (%)17 (5.8)
Primary tumour by localization ()
Pancreas, (%)91 (31.1)
 Head, (%)28 (30.7)
 Body, (%)29 (31.9)
 Tail, (%)32 (35.2)
 Not specified, (%)2 (2.2)
Jejunum-ileum, (%)71 (24.2)
Stomach, (%)40 (13.7)
 Type 1, (%)23 (57.5)
 Type 2, (%)9 (22.5)
 Type 3, (%)7 (17.5)
 Not specified, (%)1 (2.5)
Rectum, (%)25 (8.5)
Duodenum, (%)20 (6.8)
Appendix, (%)20 (6.8)
Colon, (%)16 (5.5)
Oesophagus, (%)3 (1.0)
Unknown primary tumour7 (2.4)
Tumour group by secretion
Carcinoid syndrome, positive/total studied (%)17/115 (14.8)
Gastrinoma$, positive/total studied$$ (%)4/55 (7.3)
Insulinoma&, positive/total studied&& (%)11/24 (45.8)
Tumour group by grade (); WHO, 2010
NET G1, (%)158 (64.0)
NET G2, (%)61 (24.7)
NEC, (%)28 (11.3)
Tumour group by stage (); TNM (ENETS)
Localized, (%)76 (35.5)
Locoregional, (%)43 (20.1)
Disseminated, (%)95 (44.4)

Patient was 15 y old at diagnosis, currently 22 y old at the time of the study; carcinoid syndrome criteria: times the normal value and flushing and/or diarrhea; cases with 5-HIAA quantification; $gastrinoma criteria: times the normal value and exclusion of types I and II gastric tumours; $$cases with gastrin quantification; &insulinoma criteria: hypoglycemic symptoms, Whipple triad, and/or positive 72-hour prolonged fasting test; $$cases with insulin quantification.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.